Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer

類似資料

• Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21
  著者:: Annels, Nicola E, 等
  出版事項: (2015)
• Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
  著者:: Simpson, Guy R, 等
  出版事項: (2016)
• Oncolytic Reovirus-Mediated Recruitment of Early Innate Immune Responses Reverses Immunotherapy Resistance in Prostate Tumors
  著者:: Annels, Nicola E., 等
  出版事項: (2020)
• Locoregional intravascular viral therapy of cancer: precision guidance for Paris’s arrow?
  著者:: Pencavel, T, 等
  出版事項: (2010)
• Oncolytic Viruses: Time to Compare, Contrast, and Combine?: 5th International Meeting on Replicating Oncolytic Virus Therapeutics Banff, Alberta, Canada, 18–22 March 2009
  著者:: Pandha, Hardev, 等
  出版事項: (2009)